MoneyWorks4Me

Kwality Pharmaceuticals informs about change in directorate

17 Mar 2023 Evaluate
Kwality Pharmaceuticals has informed that Prashanth Vellanki (DIN:05182633), based on recommendation of the Nomination and Remuneration Committee of the Company, has been appointed as an Additional Director (Non- Executive, Independent) on the Board of the Company with effect from 16th March, 2023, pursuant to Section 149, 150, 152 read with Schedule IV and Section 161(1) read with the Companies (Appointment and Qualification of Directors) Rules, 2014 and other applicable provisions thereof, subject to the approval of shareholders.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..